The Indiana University School of Medicine in Indianapolis and the IU School of Public Health in Bloomington are partnering with the Regenstrief Institute through a five-year, $9 million grant from the CDC to study long COVID-19.
The partnership will utilize the Indiana Network for Patient Care and the Regenstrief Notifiable Condition Detector to get data from EHRs on the prevalence of long COVID-19 symptoms, according to a Sept. 7 Regenstrief news release. Researchers will also enroll adults and children with recent infections to study the disease course and outcomes.
"Long COVID conditions include a wide range of serious health consequences that occur more than four weeks after initial viral infection. Clinicians seek to know more about them and what to expect when patients show up with them for treatment," said Shaun Grannis, MD, Regenstrief vice president for data and analytics. "Anecdotal information about long COVID abounds, but what we need is accurate, comprehensive scientific evidence. Our study will provide critical information for public health, patients and the clinicians who care for people with long COVID."